Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Immune Cell Markers in Diagnosis of Tuberculosis
Condition:   Tuberculosis Infection Intervention:   Diagnostic Test: TB-antigen responsive T cell markers Sponsor:   Tongji University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Evaluation of Centralised TB Assay Solutions
Conditions:   Tuberculosis;   Drug-resistant Tuberculosis Intervention:   Sponsor:   Foundation for Innovative New Diagnostics, Switzerland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Condition:   Tuberculosis, Pulmonary Interventions:   Drug: Atorvastatin 40mg;   Drug: Placebo oral tablet Sponsors:   University of Cape Town;   University of Zurich;   University of Namibia;   University of Bern;   University of Stellenbosch Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2019 Category: Research Source Type: clinical trials

Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Condition:   Tuberculous Meningitis Interventions:   Drug: Aspirin;   Drug: Placebo of aspirin;   Drug: WHO TBM treatment;   Drug: Intensified TBM treatment Sponsors:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   European Union;   European and Developing Countries Clinical Trials Partnership (EDCTP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2019 Category: Research Source Type: clinical trials